Research Profile

Catherine Phillips

Biography

Following a BSc. (Hons) in Biochemistry from University College Dublin and a Ph.D in Clinical Medicine from Trinity College Dublin (entitled Studies of Postprandial Lipoprotein Metabolism in Diabetes), I continued my postdoctoral research in the Royal College of Surgeons of Ireland investigating aspects of postprandial lipoprotein metabolism in type 2 diabetes and insulin resistance. I then joined the Nutrigenomics Research Group, Trinity College Dublin (and later at University College Dublin) to work on two EU 6th Framework initiatives - NuGO (European Nutrigenomics Organisation) and LIPGENE (Diet, genomics and the metabolic syndrome: an integrated nutrition, agro-food, social and economic analysis). NuGO is a Network of Excellence, linking genomics, nutrition and health research (www.nugo.org). The LIPGENE project (www.ucd.ie/lipgene) involved a prospective genetic study and a human dietary intervention trial to test the interaction between dietary fat exposure and genetic risk of the metabolic syndrome. Within LIPGENE I coordinated the prospective case-control genetic study in collaboration with INSERM U476 & U557 (Marseille and Paris) which investigated genetic associations with metabolic syndrome and its phenotypes, and whether interaction with dietary fatty acid composition modulated these relationships. I joined the HRB Centre for Diet and Health Research at University College Cork in 2011 as a Principal Investigator on the Mitchelstown cohort. This cross-sectional study of middle-aged men and women is examining the effects of dietary exposures and lifestyle factors on obesity and the metabolic syndrome - a very common, multi-component, condition characterised by insulin resistance, dyslipidaemia, abdominal obesity and hypertension that is associated with increased risk of type 2 diabetes mellitus, cardiovascular disease and atherosclerosis. This study, and its 5 year follow-up, represents a valuable resource to additionally test a range of other hypotheses relevant to diet-related disease. Current research interests focus on obesity, diabetes and cardiometabolic risk prediction, diagnosis and determinants, particularly in the context of the metabolically healthy obese phenotype.

Research Interests

Current research interests lie in obesity, diabetes and cardiometabolic risk prediction, diagnosis and determinants, particularly in the context of the metabolically healthy obese phenotype.

Research Grants

 ProjectFunding
Body
Start DateEnd DateAward
Does Physical activity modulate the pro-atherogenic effects of obesity and insulin resistance on lipoprotein particle number and size.Irish Charities01-JAN-1231-DEC-13€4,878.00

Publications

Book Chapters

 YearPublication
(2013)'Modulating the Risk of Obesity and Diabetes through Nutrigenetics'
Roche HM and Phillips CM (2013) 'Modulating the Risk of Obesity and Diabetes through Nutrigenetics' In: Nutrigenomics and Nutrigenetics in Functional Foods and Personalized Nutrition. USA: CRC Press. [Details]
(2014)'Nutrigenetics and Metabolic Disease: Current Status and Implications for Personalised Nutrition'
Phillips CM (2014) 'Nutrigenetics and Metabolic Disease: Current Status and Implications for Personalised Nutrition' In: Functional Foods: The Connection Between Nutrition, Health, and Food Science. USA: Apple Academic Press. [Details]

Peer Reviewed Journals

 YearPublication
(2017)'The Association between Dietary Quality and Dietary Guideline Adherence with Mental Health Outcomes in Adults: A Cross-Sectional Analysis'
Meegan, Amy; Perry, Ivan J.; Phillips, Catherine M. (2017) 'The Association between Dietary Quality and Dietary Guideline Adherence with Mental Health Outcomes in Adults: A Cross-Sectional Analysis'. Nutrients, 9 (3) [DOI] [CORA Link] [Details]
(2016)'Number of Days Required to Estimate Habitual Activity Using Wrist-Worn GENEActiv Accelerometer: A Cross-Sectional Study'
Dillon, C. B.,Fitzgerald, A. P.,Kearney, P. M.,Perry, I. J.,Rennie, K. L.,Kozarski, R.,Phillips, C. M. (2016) 'Number of Days Required to Estimate Habitual Activity Using Wrist-Worn GENEActiv Accelerometer: A Cross-Sectional Study'. PLoS One, 11 (55) [Details]
(2016)'Number of days required to estimate habitual activity using GENEActiv accelerometer: A cross-sectional study'
Dillon C.B, Fitzgerald A.P, Kearney P.M, Perry I.J, Rennie K.L, Kozarski R, Phillips C.M (2016) 'Number of days required to estimate habitual activity using GENEActiv accelerometer: A cross-sectional study'. Plos One, [DOI] [Details]
(2015)'Optimal Central Obesity Measurement Site for Assessing Cardiometabolic and Type 2 Diabetes Risk in Middle-Aged Adults'
Millar S.R., Perry I.J., Van den Broeck J, Phillips C.M (2015) 'Optimal Central Obesity Measurement Site for Assessing Cardiometabolic and Type 2 Diabetes Risk in Middle-Aged Adults'. Plos One, [DOI] [Details]
(2015)'Cross-sectional analysis of weekly levels and patterns of objectively-measured physical behaviour with cardiometabolic health in middle-aged adults'
Dillon C.B, Dahly D, Donnelly A.E, Kearney P.M, Perry I.J, Rennie K.L, Phillips C.M. (2015) 'Cross-sectional analysis of weekly levels and patterns of objectively-measured physical behaviour with cardiometabolic health in middle-aged adults'. Journal of Epidemiology and Community Health, [DOI] [Details]
(2015)'Daily Cumulative Patterns of Objectively-measured Physical Behaviour by Metabolic Syndrome Health Profiles in Middle-aged Adults'
Dillon C.B, Dahly D, Donnelly A.E, Kearney P.M, Perry I.J, Rennie K.L, Phillips C.M. (2015) 'Daily Cumulative Patterns of Objectively-measured Physical Behaviour by Metabolic Syndrome Health Profiles in Middle-aged Adults'. Journal of Epidemiology and Community Health, [DOI] [Details]
(2013)'Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic Risk Metabotype'
Phillips, CM;Tierney, AC;Perez-Martinez, P;Defoort, C;Blaak, EE;Gjelstad, IMF;Lopez-Miranda, J;Kiec-Klimczak, M;Malczewska-Malec, M;Drevon, CA;Hall, W;Lovegrove, JA;Karlstrom, B;Riserus, U;Roche, HM (2013) 'Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic Risk Metabotype'. Obesity, 21 :154-161 [DOI] [Details]
(2012)'High Dietary Saturated Fat Intake Accentuates Obesity Risk Associated with the Fat Mass and Obesity-Associated Gene in Adults'
Phillips, CM;Kesse-Guyot, E;McManus, R;Hercberg, S;Lairon, D;Planells, R;Roche, HM (2012) 'High Dietary Saturated Fat Intake Accentuates Obesity Risk Associated with the Fat Mass and Obesity-Associated Gene in Adults'. Journal of Nutrition, 142 :824-831 [DOI] [Details]
(2015)'Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: Does size matter?'
Perry I.J., Phillips C.M. (2015) 'Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: Does size matter?'. Atherosclerosis, 242 (2):399-406 [Details]
(2015)'Depressive symptoms, anxiety and well-being among metabolic health obese subtypes'
Perry I.J., Phillips C.M. (2015) 'Depressive symptoms, anxiety and well-being among metabolic health obese subtypes'. Psychoneuroendocrinology, 62 :47-53 [DOI] [Details]
(2015)'HbA 1c Alone Is a Poor Indicator of Cardiometabolic Risk in Middle-Aged Subjects with Pre-Diabetes but Is Suitable for Type 2 Diabetes Diagnosis: A Cross-Sectional Study'
Millar, S.R., Perry, I.J., Phillips, C.M. (2015) 'HbA 1c Alone Is a Poor Indicator of Cardiometabolic Risk in Middle-Aged Subjects with Pre-Diabetes but Is Suitable for Type 2 Diabetes Diagnosis: A Cross-Sectional Study'. Plos One, 10 (6) [Details]
(2014)'Nutrigenetics: bridging two worlds to understand type 2 diabetes'
Harrington JM, Phillips CM (2014) 'Nutrigenetics: bridging two worlds to understand type 2 diabetes'. Current Diabetes Reports, 14 (477) [Details]
(2013)'Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic Risk Metabotype'
Phillips, CM,Tierney, AC,Perez-Martinez, P,Defoort, C,Blaak, EE,Gjelstad, IMF,Lopez-Miranda, J,Kiec-Klimczak, M,Malczewska-Malec, M,Drevon, CA,Hall, W,Lovegrove, JA,Karlstrom, B,Riserus, U,Roche, HM (2013) 'Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic Risk Metabotype'. Obesity, 21 :154-161 [DOI] [Details]
(2013)'Defining metabolically healthy obesity: role of dietary and lifestyle factors'
Phillips, C. M.,Dillon, C.,Harrington, J. M.,McCarthy, V. J.,Kearney, P. M.,Fitzgerald, A. P.,Perry, I. J. (2013) 'Defining metabolically healthy obesity: role of dietary and lifestyle factors'. PLoS One, 8 (1010) [CORA Link] [Details]
(2014)'DataSHIELD: taking the analysis to the data, not the data to the analysis'
Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, Minion J, Boyd AW, Newby CJ, Nuotio ML, Wilson R, Butters O, Murtagh B, Demir I, Doiron D, Giepmans L, Wallace SE, Budin-Ljøsne I, Oliver Schmidt C, Boffetta P, Boniol M, Bota M, Carter KW, deKlerk N, Dibben C, Francis RW, Hiekkalinna T, Hveem K, Kvaløy K, Millar S, Perry IJ, Peters A, Phillips CM, Popham F, Raab G, Reischl E, Sheehan N, Waldenberger M, Perola M, van den Heuvel E, Macleod J, Knoppers BM, Stolk RP, Fortier I, Harris JR, Woffenbuttel BH, Murtagh MJ, Ferretti V, Burton PR. (2014) 'DataSHIELD: taking the analysis to the data, not the data to the analysis'. International Journal of Epidemiology, [Details]
(2013)'Defining metabolically healthy obesity: role of dietary and lifestyle factors'
Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, Perry IJ (2013) 'Defining metabolically healthy obesity: role of dietary and lifestyle factors'. Plos One, 8 (10) [DOI] [Details]
(2013)'Does inflammation determine metabolic health status in obese and nonobese adults?'
Phillips CM, Perry IJ (2013) 'Does inflammation determine metabolic health status in obese and nonobese adults?'. Clinics In Endocrinology And Metabolism, 98 (10):1-9 [DOI] [Details]
(2013)'Metabolically healthy obesity: Definitions, determinants and clinical implications'
Phillips CM (2013) 'Metabolically healthy obesity: Definitions, determinants and clinical implications'. Reviews in endocrine & metabolic disorders, 14 (3):219-227 [DOI] [Details]
(2013)'Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype'
Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM, Lopez-Miranda J, Kiec-Klimczak M, Malczewska-Malec M, Drevon CA, Hall W, Lovegrove JA, Karlstrom B, Risérus U, Roche HM (2013) 'Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype'. Obesity (Silver Spring, Md.), 21 (1):1-61 [DOI] [Details]
(2013)'Nutrigenetics and metabolic disease: current status and implications for personalised nutrition'
Phillips CM (2013) 'Nutrigenetics and metabolic disease: current status and implications for personalised nutrition'. Nutrients, 5 (1):32-57 [DOI] [Details]
(2012)'A gene variation (rs12691) in the CCAT/enhancer binding protein alpha modulates glucose metabolism in metabolic syndrome'
Delgado-Lista, J.,Perez-Martinez, P.,Garcia-Rios, A.,Phillips, C. M.,Hall, W.,Gjelstad, I. M.,Lairon, D.,Saris, W.,Kiec-Wilk, B.,Karlstrom, B.,Drevon, C. A.,Defoort, C.,Blaak, E. E.,Dembinska-Kiec, A.,Riserus, U.,Lovegrove, J. A.,Roche, H. M.,Lopez-Miranda, J. (2012) 'A gene variation (rs12691) in the CCAT/enhancer binding protein alpha modulates glucose metabolism in metabolic syndrome'. Nutr Metab Cardiovasc Dis, [Details]
(2012)'A Period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome'
Garcia-Rios, A.,Perez-Martinez, P.,Delgado-Lista, J.,Phillips, C. M.,Gjelstad, I. M.,Wright, J. W.,Karlstrom, B.,Kiec-Wilk, B.,van Hees, A. M.,Helal, O.,Polus, A.,Defoort, C.,Riserus, U.,Blaak, E. E.,Lovegrove, J. A.,Drevon, C. A.,Roche, H. M.,Lopez-Miranda, J. (2012) 'A Period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome'. J Nutr, 142 (77):1213-81213 [Details]
(2012)'Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA'
Oliver, E.,McGillicuddy, F. C.,Harford, K. A.,Reynolds, C. M.,Phillips, C. M.,Ferguson, J. F.,Roche, H. M. (2012) 'Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA'. J Nutr Biochem, 23 (99):1192-2001192 [Details]
(2012)'Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome'
Phillips, C. M.,Goumidi, L.,Bertrais, S.,Field, M. R.,McManus, R.,Hercberg, S.,Lairon, D.,Planells, R.,Roche, H. M. (2012) 'Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome'. J Nutr Biochem, 23 (33):239-44239 [Details]
(2012)'Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk'
Phillips, C. M.,Kesse-Guyot, E.,Ahluwalia, N.,McManus, R.,Hercberg, S.,Lairon, D.,Planells, R.,Roche, H. M. (2012) 'Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk'. Atherosclerosis, 220 (22):513-9513 [Details]
(2012)'Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic Risk Metabotype'
Phillips, C. M.,Tierney, A. C.,Perez-Martinez, P.,Defoort, C.,Blaak, E. E.,Gjelstad, I. M.,Lopez-Miranda, J.,Kiec-Klimczak, M.,Malczewska-Malec, M.,Drevon, C. A.,Hall, W.,Lovegrove, J. A.,Karlstrom, B.,Riserus, U.,Roche, H. M. (2012) 'Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic Risk Metabotype'. Obesity (Silver Spring), [Details]
(2012)'High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults'
Phillips, C. M.,Kesse-Guyot, E.,McManus, R.,Hercberg, S.,Lairon, D.,Planells, R.,Roche, H. M. (2012) 'High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults'. J Nutr, 142 (55):824-31824 [Details]
(2011)'Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: from the LIPGENE study'
Delgado-Lista J, Perez-Martinez P, García-Rios A, Phillips CM, Williams CM, Gulseth HL, Helal O, Blaak EE, Kiec-Wilk B, Basu S, Drevon CA, Defoort C, Saris WH, Wybranska I, Riserus U, Lovegrove JA, Roche HM, Lopez-Miranda J (2011) 'Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: from the LIPGENE study'. Atherosclerosis, 214 (1):110-116 [DOI] [Details]
(2011)'Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism'
Garcia-Rios A, Delgado-Lista J, Perez-Martinez P, Phillips CM, Ferguson JF, Gjelstad IM, Williams CM, Karlström B, Kieć-Wilk B, Blaak EE, Lairon D, Planells R, Malczewska-Malec M, Defoort C, Riserus U, Saris WH, Lovegrove JA, Drevon CA, Roche HM, Lopez-Miranda J (2011) 'Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism'. Atherosclerosis, 218 (2):416-422 [DOI] [Details]
(2011)'Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk'
Phillips, C. M.,Goumidi, L.,Bertrais, S.,Field, M. R.,McManus, R.,Hercberg, S.,Lairon, D.,Planells, R.,Roche, H. M.; (2011) 'Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk'. Atherosclerosis, 214 (22):408-14408 [Details]
(2010)'The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA'
Oliver, E.,McGillicuddy, F.,Phillips, C.,Toomey, S.,Roche, H. M.; (2010) 'The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA'. Proc Nutr Soc, 69 (22):232-43232 [Details]
(2010)'Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance'
Ferguson, J. F.,Phillips, C. M.,Tierney, A. C.,Perez-Martinez, P.,Defoort, C.,Helal, O.,Lairon, D.,Planells, R.,Shaw, D. I.,Lovegrove, J. A.,Gjelstad, I. M.,Drevon, C. A.,Blaak, E. E.,Saris, W. H.,Leszczynska-Golabek, I.,Kiec-Wilk, B.,Riserus, U.,Karlstrom, B.,Miranda, J. L.,Roche, H. M.; (2010) 'Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance'. Am J Clin Nutr, 91 (33):794-801794 [Details]
(2010)'NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids'
Ferguson, J. F; Phillips, C. M; McMonagle, J; Perez-Martinez, P; Shaw, D. I; Lovegrove, J. A; Helal, O; Defoort, C; Gjelstad, I. M; Drevon, C. A; Blaak, E. E; Saris, W. H; Leszczynska-Golabek, I; Kiec-Wilk, B; Riserus, U; Karlstrom, B; Lopez-Miranda, J; Roche, H. M.; (2010) 'NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids'. Atherosclerosis, 211 (22):539-44539 [Details]
(2010)'Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults'
Phillips, C. M; Goumidi, L; Bertrais, S; Field, M. R; Ordovas, J. M; Cupples, L. A; Defoort, C; Lovegrove, J. A; Drevon, C. A; Blaak, E. E; Gibney, M. J; Kiec-Wilk, B; Karlstrom, B; Lopez-Miranda, J; McManus, R; Hercberg, S; Lairon, D; Planells, R; Roche, H. M.; (2010) 'Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults'. J Nutr, 140 (22):238-44238 [Details]
(2010)'Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome'
Phillips, C. M; Goumidi, L; Bertrais, S; Field, M. R; Cupples, L. A; Ordovas, J. M; Defoort, C; Lovegrove, J. A; Drevon, C. A; Gibney, M. J; Blaak, E. E; Kiec-Wilk, B; Karlstrom, B; Lopez-Miranda, J; McManus, R; Hercberg, S; Lairon, D; Planells, R; Roche, H. M.; (2010) 'Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome'. J Lipid Res, 51 (77):1793-8001793 [Details]
(2010)'Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components'
Phillips, C. M; Goumidi, L; Bertrais, S; Ferguson, J. F; Field, M. R; Kelly, E. D; Mehegan, J; Peloso, G. M; Cupples, L. A; Shen, J; Ordovas, J. M; McManus, R; Hercberg, S; Portugal, H; Lairon, D; Planells, R; Roche, H. M.; (2010) 'Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components'. J Clin Endocrinol Metab, 95 (33):1386-941386 [Details]
(2010)'ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat'
Phillips, C. M.,Goumidi, L.,Bertrais, S.,Field, M. R.,Cupples, L. A.,Ordovas, J. M.,McMonagle, J.,Defoort, C.,Lovegrove, J. A.,Drevon, C. A.,Blaak, E. E.,Kiec-Wilk, B.,Riserus, U.,Lopez-Miranda, J.,McManus, R.,Hercberg, S.,Lairon, D.,Planells, R.,Roche, H. M.; (2010) 'ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat'. J Lipid Res, 51 (1212):3500-73500 [Details]
(2009)'Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome'
Phillips, C. M; Goumidi, L; Bertrais, S; Ferguson, J. F; Field, M. R; Kelly, E. D; Peloso, G. M; Cupples, L. A; Shen, J; Ordovas, J. M; McManus, R; Hercberg, S; Portugal, H; Lairon, D; Planells, R; Roche, H. M.; (2009) 'Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome'. Am J Clin Nutr, 90 (66):1665-731665 [Details]
(2009)'Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults'
Phillips, C. M; Goumidi, L; Bertrais, S; Field, M. R; Peloso, G. M; Shen, J; McManus, R; Hercberg, S; Lairon, D; Planells, R; Roche, H. M.; (2009) 'Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults'. J Nutr, 139 (1111):2011-72011 [Details]
(2008)'Gene-nutrient interactions in the metabolic syndrome'
Phillips, C. M.,Tierney, A. C.,Roche, H. M.; (2008) 'Gene-nutrient interactions in the metabolic syndrome'. J Nutrigenet Nutrigenomics, 1 (33):136-51136 [Details]
(2008)'Prediction of the metabolic syndrome status based on dietary and genetic parameters, using Random Forest'
Szabo de Edelenyi, F.,Goumidi, L.,Bertrais, S.,Phillips, C.,Macmanus, R.,Roche, H.,Planells, R.,Lairon, D.; (2008) 'Prediction of the metabolic syndrome status based on dietary and genetic parameters, using Random Forest'. Genes Nutr, 3 (3-43-4):173-6173 [Details]
(2006)'Genetic and nutrient determinants of the metabolic syndrome'
Phillips, C.,Lopez-Miranda, J.,Perez-Jimenez, F.,McManus, R.,Roche, H. M.; (2006) 'Genetic and nutrient determinants of the metabolic syndrome'. Curr Opin Cardiol, 21 (33):185-93185 [Details]
(2006)'Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition'
Phillips C, Mullan K, Owens D, Tomkin GH; (2006) 'Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition'. Atherosclerosis, 187 (1):57-64 [DOI] [Details]
(2005)'Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes'
Phillips C, Owens D, Collins P, Tomkin GH; (2005) 'Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes'. Atherosclerosis, 181 (1):109-114 [DOI] [Details]
(2005)'The metabolic syndrome: the crossroads of diet and genetics'
Roche, H. M.,Phillips, C.,Gibney, M. J.; (2005) 'The metabolic syndrome: the crossroads of diet and genetics'. Proc Nutr Soc, 64 (33):371-7371 [Details]
(2004)'Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes'
Phillips, C.,Mullan, K.,Owens, D.,Tomkin, G. H.; (2004) 'Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes'. QJM, 97 (44):211-8211 [Details]
(2002)'Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?'
Phillips C, Owens D, Collins P, Tomkin GH; (2002) 'Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?'. Atherosclerosis, 160 (2):355-360 [Details]
(2002)'Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes'
Phillips, C.,Bennett, A.,Anderton, K.,Owens, D.,Collins, P.,White, D.,Tomkin, G. H.; (2002) 'Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes'. Metabolism, 51 (77):847-52847 [Details]
(2002)'Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?'
Phillips, C.,Madigan, C.,Owens, D.,Collins, P.,Tomkin, G. H.; (2002) 'Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?'. Int J Exp Diabetes Res, 3 (33):171-8171 [Details]
(2000)'Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes'
Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH; (2000) 'Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes'. Atherosclerosis, 148 (2):283-291 [Details]

Professional Activities

Honours and Awards

 YearTitleAwarding Body
2001Finalist, Young Investigator Award, European Atherosclerosis Society. European Atherosclerosis Society.
2000European Foundation for the Study of Diabetes and Merck Travel Fellowship for Young Scientists. European Foundation for the Study of Diabetes and Merck
1998Student Travel Fellowship, European Association for the Study of Diabetes. European Association for the Study of Diabetes
1998Finalist, RCSI Sheppard Trust Prize. RCSI Sheppard Trust
1999Irish Endocrine Society Travel Fellowship. Irish Endocrine Society

Professional Associations

 AssociationFunctionFrom / To
Nutrition Society Member/
European Association for the Study of Diabetes Member/
European Nutrigenomics Organisation Member/

Contact details

Search profiles by name

Search profiles by topic

School of Public Health

Fourth floor, Adjoining Main Campus, Western Gateway Building, Western Road ,

Top